The Interplay Between Schistosomiasis and Hepatitis C Virus:Battling on Two Fronts  

作　　者：Nahed A Makhlouf Ahmed Abu-Elfatth Tasneem Khaled Mohamed El-Kassas 

机构地区：[1]Tropical Medicine and Gastroenterology Department,Faculty of Medicine,Assiut University,Assiut 71515,Egypt [2]Department of Gastroenterology and Hepatology,Aljazeera Hospital,Riyadh 14236,Saudi Arabia [3]Endemic Medicine Department,Faculty of Medicine,Helwan University,Cairo 11795,Egypt [4]Liver Disease Research Center,College of Medicine,King Saud University,Riyadh 11411,Saudi Arabia

出　　处：《Infectious Diseases & Immunity》2024年第4期187-193,共7页感染性疾病与免疫（英文）

摘　　要：Schistosomiasis is a prevalent health issue in numerous countries in Africa,Asia,and South America.Data regarding the coinfection of schistosomiasis with hepatitis C virus(HCV)is limited,yet this coinfection is prevalent in regions where schistosomiasis is endemic.The extent of the coinfection issue is evident in countries with a high prevalence of both diseases,such as Egypt.Coinfections with schistosomiasis result in more pronounced liver damage compared with an HCV infection alone.Schistosomiasis has been found to disrupt HCV-specific T-cell responses,resulting in high viral load,increased likelihood of HCV chronicity,and accelerated development of comorbidities in individuals with coinfection.Introducing new,directly acting antivirals for HCV treatment resulted in a marked shift in the disease landscape.This shift may have an impact on the incidence of coinfection with schistosomiasis.This review emphasizes the notable influence of schistosomiasis on the vulnerability to HCV coinfection,the gravity of the consequent liver pathology,and the effectiveness of HCV antiviral therapy.

关 键 词：Hepatitis C virus SCHISTOSOMIASIS Portal fibrosis Liver cirrhosis Hepatocellular carcinoma 

分 类 号：R532.21[医药卫生—内科学] R512.63[医药卫生—临床医学]